Skip to main content

Advertisement

SpringerLink
Log in

Renalase Gene Polymorphism and Epinephrine Level in Chronic Kidney Disease

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Chronic kidney disease (CKD) is an important public health problem. Patients with end-stage renal disease have a significant renalase deficiency, which could be one of the mechanisms explaining high prevalence of hypertension in these patients. The aim of this study was to investigate the possible association of renalase gene (rs2296545) polymorphism with normotensive and hypertensive CKD in sampled Egyptian patients and to determine the effect of such polymorphism on epinephrine level. Renalase gene (rs2296545) polymorphism was genotyped in 178 patients with CKD (83 normotensive and 95 hypertensive nephrosclerosis) and 178 normal healthy adults using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). Epinephrine level was measured by HPLC method. We found an association of renalase (rs2296545) CC genotype and C allele with CKD. Also, the epinephrine level was significantly increased in normotensive and hypertensive nephrosclerosis patients as compared to controls. CKD patients with CC genotype showed significant high epinephrine level as compared to CG and GG genotypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. McClellan, W. M., Satko, S. G., Gladstone, E., Krisher, J. O., Narva, A. S., & Freedman, B. I. (2009). Individuals with a family history of ESRD are a high-risk population for CKD: implications for targeted surveillance and intervention activities. American Journal of Kidney Diseases, 53(3), S100–S106.

    Article  Google Scholar 

  2. Xu, J., Wang, G., Li, P., Velazquez, H., Yao, X., Li, Y., et al. (2005). Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. Journal of Clinical Investigation, 115(5), 1275–1280.

    Article  CAS  Google Scholar 

  3. Desir, G. V. (2009). Regulation of blood pressure and cardiovascular function by renalase. Kidney International, 76, 366–370.

    Article  CAS  Google Scholar 

  4. Boomsma, F., & Tipton, K. F. (2007). Renalase, a catecholamine-metabolizing enzyme? Journal of Neural Transmission, 114, 775–776.

    Article  CAS  Google Scholar 

  5. Xu, J., & Desir, G. V. (2007). Renalase, a new renal hormone: its role in health and disease. Current Opinion in Nephrology and Hypertension, 16, 373–378.

    Article  CAS  Google Scholar 

  6. Haroun, M. K., Jaar, B. G., Hoffman, S. C., Comstock, G. W., Klag, M. J., & Coresh, J. (2003). Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington Country, Maryland. Journal of the American Society of Nephrology, 14(11), 2934–2941.

    Article  Google Scholar 

  7. Toto, R. B. (2003). Hypertensive Nephrosclerosis in African Americans. Kidney International, 64(6), 2331–2341.

    Article  Google Scholar 

  8. Hsu, C. Y., McCulloch, C. E., Darbinian, J., Go, A. S., & Iribarren, C. (2005). Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Archives of Internal Medicine, 165(8), 923–928.

    Article  Google Scholar 

  9. Farzaneh-Far, R., Desir, G. V., Na, B., Schiller, N. B., & Whooley, M. A. (2010). A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, andischemia: data from the heart and soul study. PLoS One 20, 5(10) e13496.

  10. Zhao, Q., Fan, Z., He, J., Chen, S., Li, H., Zhang, P., et al. (2007). Renalase gene is a novel susceptibility gene for essential hypertension: a two stage association study in northern Han Chinese population. Journal of Molecular Medicine, 85, 877–885.

    Article  CAS  Google Scholar 

  11. Abdallah, E., & Sabry, D. (2013). Renalase gene polymorphisms in end-stage renal disease patients: an Egyptian study. Journal of American Science, 9(1), 346–349.

    Google Scholar 

  12. Freedman, B. I., Hicks, P. J., Bostrom, M. A., Cunningham, M. E., Liu, Y., Divers, J., et al. (2009). Polymorphisms in the non-muscle myosin heavy chain 9 Gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney International, 75(7), 736–745.

    Article  CAS  Google Scholar 

  13. Fogo, A., Breyer, J. A., Smith, M. C., Cleveland, W. H., Agodoa, L., Kirk, K. A., et al. (1997). Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators. Kidney International, 51(1), 244–252.

    Article  CAS  Google Scholar 

  14. Buraczynska, M., Zukowski, P., Buraczynska, K., Mozul, S., & Ksiazek, A. (2011). Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Medicine, 13(4), 321–327.

    Article  CAS  Google Scholar 

  15. BauersfeldW, R. D., Knoll, E., & Wisser, H. (1986). Determination of catecholamines in plasma by hplc and amperometric detection. Comparison with a radioenzymatic method. Journal of Clinical Biochemistry, 24, 185–188.

    Google Scholar 

  16. SPSS for Windows Statistical Package for the Social Sciences, version 11.0.1.SPSS Inc, Chicago 2001

  17. Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., et al. (2007). Prevalence of chronic kidney disease in the United States. Journal of the American Medical Association, 298(17), 2038–2047.

    Article  CAS  Google Scholar 

  18. Ahlawat, R. S., Gupta, S., Kapoor, S., & Kar, P. (2012). Polymorphism of renalase gene in patients of chronic kidney disease. Open Journal of Nephrology, 2, 136–143.

    Article  Google Scholar 

  19. Peng, M., & Jiang, X. J. (2011). Novel renin-angiotensin-aldosterone-system-related targets for antihypertensive therapy. Advance Cardiovascular Diseases, 32, 13–16.

    CAS  Google Scholar 

  20. Li, G., Xu, J., Wang, P., Velazquez, H., Li, Y., Wu, Y., et al. (2008). Catecholamines regulate the activity, secretion, and synthesis of renalase. Circulation, 117(10), 1277–1282.

    Article  CAS  Google Scholar 

Download references

Conflict of Interest

No conflict of interest.

Author information

Authors and Affiliations

  1. Medical Biochemistry Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Noha A. Rezk & Haidy E. Zidan

  2. Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

    Yasser A. Elnaggar & Adel Ghorab

Authors
  1. Noha A. Rezk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Haidy E. Zidan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasser A. Elnaggar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adel Ghorab
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noha A. Rezk.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezk, N.A., Zidan, H.E., Elnaggar, Y.A. et al. Renalase Gene Polymorphism and Epinephrine Level in Chronic Kidney Disease. Appl Biochem Biotechnol 175, 2309–2317 (2015). https://doi.org/10.1007/s12010-014-1433-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-014-1433-x

Keywords

Search

Navigation